Viewing Study NCT06648733



Ignite Creation Date: 2024-10-26 @ 3:43 PM
Last Modification Date: 2024-10-26 @ 3:43 PM
Study NCT ID: NCT06648733
Status: RECRUITING
Last Update Posted: None
First Post: 2024-06-27

Brief Title: Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
Sponsor: None
Organization: None

Study Overview

Official Title: Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care Optimierung Der Pharmakologischen Überleitung Von PalliativpatientInnen Von stationär Nach Ambulant
Status: RECRUITING
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EntMedPall
Brief Summary: The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist This data will be compared with retrospective cases
Detailed Description: As part of a prospective observational study with a retrospective comparison group a pharmacist should on request check the discharge medication planned by the primary care physicians before discharge and discuss it with the various colleagues providing follow-up care In addition the availability in the outpatient medicine cabinet and the possibility of prescribing by the responsible GPs by telephone should be checked in advance In addition longitudinal focus groups with relevant stakeholders are to be conducted to collect quantitative data as well as qualitative data on the views of those providing and receiving treatment

There will be cooperation with the Specialized Outpatient Palliative Care Service Muenster to ensure sufficient case numbers and a low rate of missing values through partial use of the standard care data from the Information System Palliative Care ISPC program they use

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None